In the last trading session, 1.12 million CERo Therapeutics Holdings Inc (NASDAQ:CERO) shares changed hands as the company’s beta touched 0.51. With the company’s per share price at $0.58 changed hands at -$0.02 or -3.47% during last session, the market valuation stood at $4.49M. CERO’s last price was a discount, traded about -18865.52% off its 52-week high of $110.00. The share price had its 52-week low at $0.53, which suggests the last value was 8.62% up since then.

CERo Therapeutics Holdings Inc (NASDAQ:CERO) trade information

Instantly CERO was in red as seen at the end of in last trading. With action -1.39%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -90.30%, with the 5-day performance at -1.39% in the red. However, in the 30-day time frame, CERo Therapeutics Holdings Inc (NASDAQ:CERO) is -8.87% down.

The 2025 estimates are for CERo Therapeutics Holdings Inc earnings to increase by 73.05%, but the outlook for the next 5-year period is at 57.22% per year.

CERO Dividends

CERo Therapeutics Holdings Inc is expected to release its next quarterly earnings report in June.

Among Mutual Funds, the top two as of Mar 31, 2025 were Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund . With 13.69 shares estimated at $7966.0 under it, the former controlled 0.18% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund held about 0.01% of the shares, roughly 1.12 shares worth around $651.0.